Overharvesting is one of the greatest threats to species survival. Farming overharvested species is a conservation strategy that can meet growing market demand and conserve wild populations of the target species. This strategy is compatible with the international community's desire to uphold the right of local communities to use biological resources to support their livelihoods. However, studies investigating whether farming can alleviate poaching pressure have focused almost exclusively on animals. To address the shortfall in plant-focused studies, we compiled information on commercial cultivation of threatened plants to assess its conservation benefits. Because China's rising middle class has rapidly intensified demand for wildlife products, we searched the scientific literature published in Chinese (China National Knowledge Infrastructure and Baidu) and in English. We found 32 reports that contained data on 193 internationally or nationally threatened plant species that were under commercial cultivation. These reports showed that cultivations of 82% of the 193 species were sustained by collecting whole plants from the wild periodically or continuously. Although based on a small sample size, species that were maintained in cultivation only through artificial propagation or seeds collected in the wild were likely associated with a reported reduction in wild harvesting of whole plants. Even so, results of correlation analyses suggested that production system, scale, and when a species began being cultivated had little effect on conservation status of the species, either globally or in China. However, species brought into cultivation relatively recently and on a smaller scale were more likely to have undergone a reduction in collecting pressure. Farming of nonmedicinal plants was most problematic for species conservation because wild plants were laundered (i.e., sold as cultivated plants). For effective conservation, policy to guide cultivation operations based on the target species' biological characteristics, cultural significance, market demand, and conservation status is needed.
Despite the grave threat illegal wildlife trade poses to species survival, few studies have attempted to link supply and demand data for the same wildlife product. All ca. 29,000 orchid species are listed by the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) and many are protected under domestic legislation too, but a growing body of evidence suggests that orchids continue to be subject to unsustainable harvesting and undocumented trade. South China is a known black spot for trade in wild-collected ornamental orchids but understanding of the drivers determining the flow of species diversity, volume and value remains wanting. We conducted systematic monthly surveys at five markets along a West-East transect from Yunnan to Hong Kong for one year, recording variables including species, numbers of individuals, weight and price. Although wild orchid diversity is highest in Yunnan, the diversity of orchids in trade increased eastwards and mean price per stem rose more than four-fold, albeit always significantly cheaper than that for artificially produced hybrids. Part of this trade appears to be in breach of CITES. Few orchids in trade conformed to six criteria highlighted in prior demand-side studies as being of higher utility value, but most conformed to a combination of four or more, suggesting that vendors can readily offer products that meet a majority of consumer preferences. Effective supply-side regulation, through government intervention and social media campaigns, is needed to facilitate behavioural change and allow artificially propagated plants to compete in the market-place.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.